Alexander Roesch
@RoeschAlexanderTumor heterogeneity & plasticity, therapy of melanoma, liquid biopsy, dermatooncology. "Let biology guide your way" ... and of course fly fishing
Similar User
@HaassLab
@d_peeper
@jonsson_lab
@lab_marine
@pozniak_joanna
@AndrewEAplin
@adri_sanna
@VitoRebecca1
@TheStarkLab
@LabSmalley
@ShainLab
@FaneMitchell
@BertolottoLab
@PASPCR1
@hemmo_lab
New content 🌟Perspective🌟 "Targeting therapy-persistent residual disease" by Xiaoxiao Sun, Lani Wu, Steven Altschuler & Aaron Hata @ucsfpharmacy @MGHCancerCenter 🔗nature.com/articles/s4301…
⏰ Nur noch eine Woche, dann startet der Deutsche #Hautkrebskongress in #Würzburg! Melden Sie sich jetzt an! Alle Infos finden Sie auf der Tagungs-Website: 👉 ado-kongress.de #ADO2024 #Onkologie #ForumHautkrebs #HautkrebsNetzwerk #Hautkrebs #Melanom #skincancer
Revisit @jasonlukemd and @AdnanKhattakOnc's recent publication summarizing the latest top advances in #melanoma research: acsjournals.onlinelibrary.wiley.com/doi/full/10.10… @OncoAlert #ESMO24
As part of our partnership with @AmericanCancer 🇺🇸Journals, @OncoAlert 🚨Proudly presents CANCER Section Editor @jasonlukemd who presented presents original research during the #melanoma mini oral session at #ESMO24 Revisit his article cowritten with @AdnanKhattakOnc on the…
🔬✨Join us for this exciting lecture hosted by CRU337 @dfg_public as part of the "Sex and Gender in the Life Sciences" series @unidue . Discover the analytical potential of sex differences in melanoma.🔗Join: uni-due.zoom-x.de/j/68548836739?… #SexGenderUDE #sexandgendersensitive medicine
Congrats! Very important observation and conceptual (cancer overarching) framework.
⚠️⚠️⚠️Publication alert!⚠️⚠️⚠️ nature.com/articles/s4155… Congratulations #BrabletzLab and @KoeberleLab for this amazing study. Happy to have played a tiny role #ferroptosis #lipidmetabolism #cancerplasticity
Congrats 👏👏👏
🎊Congratulations to Dr. Renata Varaljai @renivaraljai from the Roesch lab @LabRoesch for receiving the Top Young Science Best Paper Award 2024 from the UDE Medical Faculty! 🔬🏆Read the awarded paper here: nature.com/articles/s4301…
Highlights from this year’s @crc1430 retreat in beautiful Zons! Big thanks to everyone for the exciting talks and fantastic poster sessions. #Science #Collaboration #CRC1430
🎊Congratulations to Dr. Renata Varaljai @renivaraljai from the Roesch lab @LabRoesch for receiving the Top Young Science Best Paper Award 2024 from the UDE Medical Faculty! 🔬🏆Read the awarded paper here: nature.com/articles/s4301…
OPEN POSITION! Our clinic (Clinic for Dermatology at the University Hospital Essen, Germany) offers an attractive #job opportunity for a senior physician in the field of interventional phlebology. karriere.ume.de/job-finder/?ge… Feel free to share!
Exciting scientific exchange at the annual @crc1430 retreat on the banks of river Rhine
Thank you so much for the invitation! I am looking forward to it. @unidue_zmb @SEFAGIA_ @WAutophagy @MedEssen
Exciting visit @crc1430 @unidue! We have the pleasure of hosting Silvia Vega-Rubín-de-Celis @vega_rubin from the Institute of Cell Biology @UniklinikEssen for a talk on the 'Targeting autophagic vulnerabilities for cancer treatment'. See you tomorrow on June 4th!
Novelty needs time. For the first 3 years after publication, a highly novel paper is less likely to be cited than a relatively non-novel paper. But after 15 years, they are 60% more likely to be highly cited. Don't let the short-term view discourage risky research!
Why does Elsevier @ElsevierConnect promote racial profiling by asking reviewers about race, gender etc. Scientific review should be independent of any such thing and solely focused on scientific content.
This study adds to recent studies bringing IL2 back into the spotlight (nature.com/articles/s4158…) and further highlights precision targeting of immunostimulatory signals to specific immune cell populations as a promising therapeutic strategy 12/n
Utilizing the patient-derived tumor fragment (PDTF) platform previously developed by the lab (nature.com/articles/s4159…, sciencedirect.com/science/articl…), we investigated whether and how CD8-IL2 can reinvigorate antitumor T cell immunity in human tumors 6/n
Excited to be at the 20th #SMR congress in Philadelphia, where @RoeschAlexander talked about how IL-17 affects response to dual immune checkpoint inhibition.
United States Trends
- 1. $CUTO 9.627 posts
- 2. ICBM 147 B posts
- 3. #KashOnly 22,2 B posts
- 4. The ICC 113 B posts
- 5. Good Thursday 28,7 B posts
- 6. #ThursdayVibes 4.048 posts
- 7. International Criminal Court 59,5 B posts
- 8. Gallant 149 B posts
- 9. #ThursdayMotivation 5.594 posts
- 10. Katie Couric N/A
- 11. Bezos 1.418 posts
- 12. Dnipro 60,4 B posts
- 13. Happy Friday Eve N/A
- 14. $BTC 845 B posts
- 15. Adani 838 B posts
- 16. #21Nov 3.395 posts
- 17. Vegito 2.669 posts
- 18. #thursdaytechnology N/A
- 19. Reece James 10,2 B posts
- 20. Nikki Haley 31,8 B posts
Who to follow
-
Haass_Melanoma_lab
@HaassLab -
Daniel Peeper
@d_peeper -
JonssonMelanomaLab
@jonsson_lab -
MarineLab
@lab_marine -
Joanna Pozniak
@pozniak_joanna -
Aplin Lab - Cancer Research
@AndrewEAplin -
Adriana S.
@adri_sanna -
Vito Rebecca
@VitoRebecca1 -
Mitchell Stark
@TheStarkLab -
Keiran Smalley
@LabSmalley -
Hunter Shain
@ShainLab -
Mitchell Fane
@FaneMitchell -
Corine Bertolotto
@BertolottoLab -
PASPCR
@PASPCR1 -
HemmoMeyerLab
@hemmo_lab
Something went wrong.
Something went wrong.